Plaque buildup in arteries treatment
Pro Research Analysisby 
Searched over 200M research papers
Medical Treatments for Plaque Buildup in Arteries
Plaque buildup in arteries, known as atherosclerosis, is a major cause of heart disease and stroke. Medical treatments focus on lowering cholesterol, reducing inflammation, and preventing complications. Statins, such as rosuvastatin, are widely used to lower LDL cholesterol and have been shown to significantly reduce blood pressure and improve cholesterol profiles in patients with high cholesterol and hypertension, making them a potent option for managing plaque buildup compared to dietary interventions like Indian dates . Beta-blockers are also commonly prescribed to manage symptoms and reduce the risk of heart attacks, especially after acute cardiac events, although their long-term benefit may decrease over time . Comprehensive management often includes lifestyle changes, medications, and, when necessary, procedures to restore blood flow .
Innovative Noninvasive and Minimally Invasive Therapies
Ultrasound and Laser-Based Plaque Removal
Recent research has explored advanced techniques for physically removing plaque from arteries. Ultrasound-assisted laser ablation combines focused ultrasound with laser pulses to enhance the mechanical disruption of plaque, allowing for more efficient removal of lipid deposits with lower laser power, which may improve safety and effectiveness compared to laser-only treatments 24. Catheter-assisted pulsed focused ultrasound (FUS) is another minimally invasive approach that uses a catheter to deliver focused ultrasound energy, inducing cavitation that mechanically breaks down plaque. This method has shown significant removal of lipid tissue in both animal and human plaque samples, demonstrating its potential as a safe and effective therapy .
Piezocatalytic Therapy
A novel noninvasive approach uses piezoelectric materials that generate reactive radicals under ultrasound stimulation. These materials, such as BaTiO3/Ta4C3 MXene nanosheets, accumulate in plaques and are taken up by inflammatory macrophages. When activated by ultrasound, they trigger macrophage apoptosis and reduce plaque progression, as demonstrated in animal models. This method significantly decreased plaque burden and inflammation, offering a promising new direction for early-stage atherosclerosis treatment .
Targeted Nanotechnology and Biological Approaches
Nanoparticle-Based Delivery
Targeted nanotechnology is being developed to deliver therapeutic agents directly to atherosclerotic plaques. Monocyte-mimicking nanoparticles are designed to home in on inflamed arterial regions, enhancing the delivery of drugs or imaging agents specifically to diseased sites. These nanoparticles have shown high uptake by endothelial cells and selective accumulation in atherosclerotic arteries in animal studies, suggesting a promising strategy for targeted therapy .
Exosome-Mediated Gene Therapy
Another emerging approach involves using exosomes—tiny vesicles released by cells—to deliver genetic material that can boost cholesterol removal from artery walls. For example, exosomes loaded with anti-miR-33a-5p antagomirs can increase the expression of cholesterol export proteins, potentially reducing plaque buildup. While this strategy has shown successful delivery in animal models, further refinement is needed to enhance its effectiveness .
Stabilizing Plaques and Preventing Rupture
Research is also focused on stabilizing existing plaques to prevent dangerous ruptures that can lead to heart attacks or strokes. Modifying certain proteins or targeting specific cell types within plaques, such as macrophages and fibroblasts, may help regulate plaque stability and reduce inflammation. These findings highlight new potential targets for future therapies aimed at making plaques less likely to cause complications .
Conclusion
Treating plaque buildup in arteries involves a combination of established medical therapies, such as statins and beta-blockers, and innovative new approaches, including ultrasound-assisted ablation, piezocatalytic therapy, and targeted nanotechnology. These emerging treatments aim to directly remove or stabilize plaques, reduce inflammation, and improve the safety and effectiveness of current interventions. Ongoing research continues to expand the options available for managing and potentially reversing atherosclerosis, offering hope for better outcomes in the future.
Sources and full results
Most relevant research papers on this topic
Ultrasound-Driven Piezoelectric Heterostructures Block Early Atherosclerotic Plaques Progression.
BTOMX nanosheets effectively block early atherosclerotic plaque progression by targeting inflammation-related macrophages and promoting macrophage apoptosis under ultrasound stimulation.
Investigating the potential of catheter-assisted pulsed focused ultrasound ablation for atherosclerotic plaques
Catheter-assisted focused ultrasound therapy is a feasible minimally invasive technique for removing atherosclerotic plaques, potentially improving blood vessel recanalization.
A feasibility study on removing lipid deposition in atherosclerotic plaques with ultrasound-assisted laser ablation
Ultrasound-assisted laser ablation effectively removes lipid depositions in atherosclerotic plaques, potentially improving treatment safety and efficiency.
Abstract 231: Monocyte-mimicking Nanoparticles For Atherosclerosis-targeted Therapy
Monocyte-mimicking nanoparticles (MNPs) enhance the site-specific delivery of theranostic agents for targeted atherosclerosis therapy, with higher uptake efficiency by vascular endothelial cells.
Exosome-Mediated Transfer of X-Motif-Tagged Anti-MiR-33a-5p Antagomirs to the Medial Cells of Transduced Rabbit Carotid Arteries
This study shows that endothelial cells can deliver anti-miR-33a-5p into rabbit arteries, offering a potential new treatment for atherosclerosis.
Plaque stabilizing and destabilizing effects in atherosclerosis
Modification of PDGF-B protein enhances plaque stability and stimulates blood inflammation, while inhibition of a glycolytic enzyme in macrophages leads to fatty liver disease.
DOI